Genting Singapore Ltd
SGX:G13
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genting Singapore Ltd
SGX:G13
|
SG |
|
A
|
AFC Energy PLC
F:QC8
|
UK |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
US |
|
A
|
Adtalem Global Education Inc
DUS:DVY
|
US |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Kerry Group PLC
OTC:KRYAY
|
IE |
|
Boralex Inc
TSX:BLX
|
CA |
|
G
|
Greencoat Renewables PLC
LSE:GRP
|
IE |
Wall St Price Targets
G13 Price Targets Summary
Genting Singapore Ltd
According to Wall Street analysts, the average 1-year price target for G13 is 0.838 SGD with a low forecast of 0.606 SGD and a high forecast of 1.124 SGD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G13's stock price target?
Price Target
0.838
SGD
According to Wall Street analysts, the average 1-year price target for G13 is 0.838 SGD with a low forecast of 0.606 SGD and a high forecast of 1.124 SGD.
What is the Revenue forecast for Genting Singapore Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for Genting Singapore Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Genting Singapore Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 8 years is 10%.
